ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,041 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryBaselVersameb AG
Versameb AG Logo
Verified· 3 sources

Versameb AG

Summary

About the company

The core activity of Versameb is the development of therapeutic solutions, particularly in the fields of dermatology, oncology and mycology, based on a proprietary platform technology.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
✓ Offered7
RNA therapeutics
RNA-based therapeutics for targeted up- or downregulation of proteins, with applications in immunological disorders, oncology and myology.
VERSagile research and development platform
VERSagile platform for nucleotide therapies with the pillars Protein Secretion and Multi-protein target, for developing new molecules and therapeutic concepts.
Drug development for stress urinary incontinence
Development of a lead molecule in an advanced preclinical phase for the treatment of stress urinary incontinence, focusing on functional recovery and tissue regeneration.
Drug development for solid tumors
Development of RNA drug candidates to modulate the tumor microenvironment in solid tumors by simultaneously upregulating and suppressing multiple targets.
Drug development for immunological disorders
Development of RNA-based molecules to regulate the immune response in areas where immunomodulatory treatment approaches are needed.
Drug development in myology
Development of RNA therapeutic molecules for myology indications with regenerative and protein-regulating approaches.
Partnerships for RNA therapies
Partnerships to jointly use the VERSagile platform with selected partners who want to apply optimized mRNA to medical need scenarios.
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
Press

Media

January 11, 2021Media
New leaders on the executive floor
startupticker.ch

Knowledge

No knowledge articles yet

Once Versameb AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Versameb AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Versameb AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Versameb AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Hochbergerstr. 60C
4057 Basel
Opening hours
Mon
09:00 - 18:00
Tue
09:00 - 18:00
Wed
09:00 - 18:00
Thu
09:00 - 18:00
Fri
09:00 - 17:00
Sat
Closed
Sun
Closed

At a glance

Legal form
Corporation
UID
CHE-404.818.740
Founded
2017 · 9 years
Last commercial register change
October 9, 2025
Employees
11 to 20

Similar companies

ST
Skyhawk Therapeutics Europe GmbH
Basel
CT
Cimeio Therapeutics AG
Basel
MR
Monte Rosa Therapeutics AG
Basel
MB
MabTree Biologics AG
Basel
BA
BioVersys AG
Basel
RG
RXcel GmbH
Basel
CD
CORETAG Diagnostics AG
Basel
YA
Ymmunobio AG
Riehen